Avaneesh Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.80 M
- Revenue Growth 10.57%
- Profit Growth -96.84%
- Ebitda -6.22%
- Net Worth 0.69%
- Total Assets 0.83%
About Avaneesh Pharmaceuticals
Avaneesh Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 April 2016 (Eight years and nine months 21 days old ). Its registered office is in Jalgaon, Maharashtra, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.80 M.
Pranjali Deshmukh and Yogesh Deshmukh serve as directors at the Company.
Company Details
-
Location
Jalgaon, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909MH2016PTC279941
-
Company No.
279941
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Apr 2016
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Avaneesh Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranjali Deshmukh
|
Director | 12-Apr-2016 | Current |
|
Yogesh Deshmukh
|
Director | 12-Apr-2016 | Current |
Financial Performance of Avaneesh Pharmaceuticals.
Avaneesh Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 10.57% increase. The company also saw a substantial fall in profitability, with a 96.84% decrease in profit. The company's net worth moved up by a moderate rise of 0.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avaneesh Pharmaceuticals?
Unlock access to Avaneesh Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Avaneesh Welfare FoundationPranjali Deshmukh and Yogesh Deshmukh are mutual person
Charges (Loans)
₹0.80 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jul 2023 | Canara Bank | ₹0.80 M | Open |
How Many Employees Work at Avaneesh Pharmaceuticals?
Unlock and access historical data on people associated with Avaneesh Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avaneesh Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avaneesh Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.